About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
International Journal of Hematologic Oncology
›
top-articles
International Journal of Hematologic Oncology
1.2
(top 50%)
impact factor
212
(top 50%)
papers
517
(top 50%)
citations
11
(top 50%)
h
-index
1.4
(top 50%)
extended IF
252
all documents
571
doc citations
18
(top 50%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Targeting hypoxia in the leukemia microenvironment
International Journal of Hematologic Oncology
2013
45
2
Current trends in the management of Richter's syndrome
International Journal of Hematologic Oncology
2018
42
3
Management of older adults with acute lymphoblastic leukemia: challenges & current approaches
International Journal of Hematologic Oncology
2018
26
4
Defibrotide for the treatment of hepatic veno-occlusive disease/sinusoidal obstruction syndrome with multiorgan failure
International Journal of Hematologic Oncology
2017
24
5
Dielectrophoretic recovery of DNA from plasma for the identification of chronic lymphocytic leukemia point mutations
International Journal of Hematologic Oncology
2016
22
6
Erythrocyte encapsulated
l
-asparaginase (GRASPA) in acute leukemia
International Journal of Hematologic Oncology
2016
20
7
Nuclear transport inhibition in acute myeloid leukemia: recent advances and future perspectives
International Journal of Hematologic Oncology
2018
18
8
Pregnancy outcomes in patients treated with bosutinib
International Journal of Hematologic Oncology
2020
17
9
Long-term outcomes of rituximab, temozolomide and high-dose methotrexate without consolidation therapy for lymphoma involving the CNS
International Journal of Hematologic Oncology
2017
15
10
Mechanisms of mixed-lineage leukemia
International Journal of Hematologic Oncology
2013
14
11
Approaches for the prevention of graft-versus-host disease following hematopoietic cell transplantation
International Journal of Hematologic Oncology
2015
13
12
Adhesion molecules in multiple myeloma oncogenesis and targeted therapy
International Journal of Hematologic Oncology
2022
13
13
Methods for reducing delays in the diagnosis of multiple myeloma
International Journal of Hematologic Oncology
2019
12
14
Current approaches to the initial treatment of symptomatic multiple myeloma
International Journal of Hematologic Oncology
2013
11
15
Anti-CD19 chimeric antigen receptor T-cell therapy in B-cell lymphomas: current status and future directions
International Journal of Hematologic Oncology
2021
11
16
Initial management strategies for follicular lymphoma
International Journal of Hematologic Oncology
2012
10
17
Five-year direct costs of acute lymphoblastic leukemia pediatric patients undergoing allogeneic stem cell transplant
International Journal of Hematologic Oncology
2016
10
18
Pediatric cancer, posttraumatic stress and fear-related neural circuitry
International Journal of Hematologic Oncology
2019
10
19
Venetoclax: a real game changer in treatment of chronic lymphocytic leukemia
International Journal of Hematologic Oncology
2020
10
20
Understanding the molecular basis of acute myeloid leukemias: where are we now?
International Journal of Hematologic Oncology
2017
9
21
Chart review across EU5 in MM post-ASCT patients
International Journal of Hematologic Oncology
2018
9
22
First Italian birth after cryopreserved ovarian tissue transplantation in a patient affected by non-Hodgkin's lymphoma
International Journal of Hematologic Oncology
2018
9
23
Checkpoint inhibition of PD-L1 and CTLA-4 in a child with refractory acute leukemia
International Journal of Hematologic Oncology
2019
9
24
Immune dysfunction in multiple myeloma
International Journal of Hematologic Oncology
2013
8
25
New approaches to manipulate minimal residual disease after allogeneic stem cell transplantation
International Journal of Hematologic Oncology
2013
8
26
A Phase I/II first-line study of R-CHOP plus B-cell receptor/NF-κB-double-targeting to molecularly assess therapy response
International Journal of Hematologic Oncology
2019
7
27
Targeting B-cell receptor signaling in leukemia and lymphoma: how and why?
International Journal of Hematologic Oncology
2016
6
28
Targeted therapies in the treatment of adult acute myeloid leukemias: current status and future perspectives
International Journal of Hematologic Oncology
2016
6
29
Diagnostic and treatment of adult Philadelphia chromosome-positive acute lymphoblastic leukemia
International Journal of Hematologic Oncology
2016
6
30
Early mortality and survival in older adults with acute myeloid leukemia
International Journal of Hematologic Oncology
2017
6
31
Acute myeloid leukemia: potential for new therapeutic approaches targeting mRNA translation pathways
International Journal of Hematologic Oncology
2013
5
32
Mast cell leukemia: a review
International Journal of Hematologic Oncology
2014
5
33
T-cell immune suppression in patients with hematologic malignancies: clinical implications
International Journal of Hematologic Oncology
2014
5
34
Current first- and second-line treatment options in acute promyelocytic leukemia
International Journal of Hematologic Oncology
2016
5
35
Targeting sphingosine kinase 1 in acute myeloid leukemia: translation to clinic
International Journal of Hematologic Oncology
2017
5
36
Globulin fraction and albumin: globulin ratio as a predictor of mortality in a South African multiple myeloma cohort
International Journal of Hematologic Oncology
2020
5
37
Gene mutation spectrum of patients with myelodysplastic syndrome and progression to acute myeloid leukemia
International Journal of Hematologic Oncology
2021
5
38
Minimal residual disease testing in acute leukemia
International Journal of Hematologic Oncology
2013
4
39
Untreated chronic lymphocytic leukemia in Lebanese patients: an observational study using standard karyotyping and FISH
International Journal of Hematologic Oncology
2017
4
40
Isolated hypoglossal nerve palsy as a presenting symptom of metastatic peripheral T-cell lymphoma – not otherwise specified (PTCL–NOS): a unique case & a review of the literature
International Journal of Hematologic Oncology
2018
4
41
Radioimmunotherapy-based conditioning regimen prior to autologous stem cell transplantation in non-Hodgkin lymphoma
International Journal of Hematologic Oncology
2018
4
42
The role of FISH in hematologic cancer
International Journal of Hematologic Oncology
2012
3
43
Autologous hematopoietic stem cell transplantation and maintenance therapy for multiple myeloma
International Journal of Hematologic Oncology
2013
3
44
Graft-versus-host disease in children after hematopoietic cell transplantation: potential clinical utility of biomarkers
International Journal of Hematologic Oncology
2015
3
45
Primary diffuse large B-cell lymphoma of the CNS: a rare case of spontaneous remission
International Journal of Hematologic Oncology
2017
3
46
An observational study of Chinese adults with relapsed/refractory Philadelphia-negative acute lymphoblastic leukemia
International Journal of Hematologic Oncology
2018
3
47
Evaluation of multiplexed biomarkers in assessment of CSF infiltration in pediatric acute lymphoblastic leukemia
International Journal of Hematologic Oncology
2019
3
48
Safety and efficacy of netupitant/palonosetron and dexamethasone in classical Hodgkin’s lymphoma patients with inadequate chemotherapy-induced nausea and vomiting prophylaxis with palonosetron and dexamethasone: a single-center real-life experience
International Journal of Hematologic Oncology
2020
3
49
Incidence of venous thrombosis after peg-asparaginase in adolescent and young adults with acute lymphoblastic leukemia
International Journal of Hematologic Oncology
2020
3
50
MALT1 paracaspase: a unique protease involved in B-cell lymphomagenesis
International Journal of Hematologic Oncology
2013
2
site/software ©
exaly
; All materials licenced under
CC by-SA
.